Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HBT1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 147 | 151 | PF00656 | 0.556 |
CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.337 |
CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.207 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.348 |
DEG_Nend_UBRbox_4 | 1 | 2 | PF02207 | 0.443 |
DOC_CDC14_PxL_1 | 139 | 147 | PF14671 | 0.575 |
DOC_MAPK_MEF2A_6 | 179 | 188 | PF00069 | 0.260 |
DOC_PP2B_LxvP_1 | 140 | 143 | PF13499 | 0.604 |
DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.760 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.633 |
DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.337 |
DOC_USP7_MATH_1 | 32 | 36 | PF00917 | 0.338 |
DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.753 |
LIG_Actin_WH2_2 | 90 | 106 | PF00022 | 0.428 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.553 |
LIG_FHA_1 | 179 | 185 | PF00498 | 0.194 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.307 |
LIG_FHA_1 | 82 | 88 | PF00498 | 0.407 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.720 |
LIG_FHA_2 | 224 | 230 | PF00498 | 0.308 |
LIG_LIR_Nem_3 | 229 | 235 | PF02991 | 0.414 |
LIG_SH2_CRK | 210 | 214 | PF00017 | 0.303 |
LIG_SH2_PTP2 | 217 | 220 | PF00017 | 0.254 |
LIG_SH2_SRC | 200 | 203 | PF00017 | 0.252 |
LIG_SH2_SRC | 217 | 220 | PF00017 | 0.225 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.238 |
LIG_SH2_STAT5 | 3 | 6 | PF00017 | 0.295 |
LIG_SUMO_SIM_anti_2 | 180 | 186 | PF11976 | 0.180 |
LIG_TYR_ITIM | 215 | 220 | PF00017 | 0.210 |
MOD_CDK_SPxxK_3 | 161 | 168 | PF00069 | 0.573 |
MOD_CK1_1 | 133 | 139 | PF00069 | 0.379 |
MOD_CK1_1 | 224 | 230 | PF00069 | 0.303 |
MOD_CK1_1 | 35 | 41 | PF00069 | 0.371 |
MOD_CK1_1 | 86 | 92 | PF00069 | 0.334 |
MOD_CK2_1 | 156 | 162 | PF00069 | 0.760 |
MOD_CK2_1 | 223 | 229 | PF00069 | 0.256 |
MOD_CK2_1 | 4 | 10 | PF00069 | 0.368 |
MOD_CMANNOS | 135 | 138 | PF00535 | 0.609 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.284 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.737 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.351 |
MOD_N-GLC_1 | 32 | 37 | PF02516 | 0.179 |
MOD_NEK2_1 | 178 | 183 | PF00069 | 0.252 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.418 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.463 |
MOD_Plk_2-3 | 71 | 77 | PF00069 | 0.462 |
MOD_Plk_4 | 178 | 184 | PF00069 | 0.327 |
MOD_Plk_4 | 191 | 197 | PF00069 | 0.245 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.280 |
MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.747 |
MOD_SUMO_rev_2 | 202 | 209 | PF00179 | 0.284 |
MOD_SUMO_rev_2 | 71 | 80 | PF00179 | 0.386 |
TRG_ENDOCYTIC_2 | 217 | 220 | PF00928 | 0.238 |
TRG_ENDOCYTIC_2 | 232 | 235 | PF00928 | 0.363 |
TRG_ER_diArg_1 | 59 | 61 | PF00400 | 0.378 |
TRG_NES_CRM1_1 | 192 | 205 | PF08389 | 0.252 |
TRG_Pf-PMV_PEXEL_1 | 92 | 96 | PF00026 | 0.416 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3J1 | Leptomonas seymouri | 58% | 73% |
A0A1X0NXM7 | Trypanosomatidae | 41% | 95% |
A0A3Q8IF47 | Leishmania donovani | 76% | 73% |
A0A3R7N4N0 | Trypanosoma rangeli | 39% | 91% |
A4HZM6 | Leishmania infantum | 76% | 73% |
D0A1E0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 97% |
E9AV55 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 73% |
Q4QCC6 | Leishmania major | 77% | 100% |
V5BDR4 | Trypanosoma cruzi | 36% | 91% |